Nonmelanoma skin cancer chemoprevention

Dermatol Surg. 2011 Nov;37(11):1566-78. doi: 10.1111/j.1524-4725.2011.02108.x. Epub 2011 Sep 2.

Authors

Renata Prado¹, Shayla O Francis, Mariah N Mason, Gregory Wing, Ryan G Gamble, Robert Dellavalle

Affiliation

¹ Department of Dermatology, School of Medicine, University of Colorado, Aurora, Colorado, USA. renata.prado@ucdenver.edu

PMID: 21895847
DOI: 10.1111/j.1524-4725.2011.02108.x

No abstract available

Publication types

Review

MeSH terms

Acitretin / therapeutic use
Aminolevulinic Acid / analogs & derivatives
Aminolevulinic Acid / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Antineoplastic Agents / therapeutic use
Carcinoma, Basal Cell / prevention & control*
Carcinoma, Squamous Cell / prevention & control*
Deoxyribonuclease (Pyrimidine Dimer) / therapeutic use
Eflornithine / therapeutic use
Humans
Monoterpenes / therapeutic use
Peroxisome Proliferator-Activated Receptors / therapeutic use
Photochemotherapy
Photosensitizing Agents / therapeutic use
Polyphenols / therapeutic use
Retinoids / adverse effects
Retinoids / therapeutic use
Skin Neoplasms / prevention & control*
Viral Proteins / therapeutic use

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antineoplastic Agents
Monoterpenes
Peroxisome Proliferator-Activated Receptors
Photosensitizing Agents
Polyphenols
Retinoids
Viral Proteins
perillyl alcohol
methyl 5-aminolevulinate
Aminolevulinic Acid
endonuclease V, phage T4
Deoxyribonuclease (Pyrimidine Dimer)
Acitretin
Eflornithine